BioMarin Pharmaceutical

9 Notable Biotechs Presenting At This Year's ASH Meeting (Dec. 9-12)

Following Q2 Beat, Sarepta Has A Key Catalyst Coming In Q4

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Following Q2 Beat, Sarepta Has A Key Catalyst Coming In Q4

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Short Sellers Dump Amgen And Baxalta

Big Biotech In The Earnings Spotlight

Short Sellers Dump Amgen And Baxalta

Big Biotech In The Earnings Spotlight

Barron's Recap: 16 All-Star Women Financial Advisors

Short Sellers Shy Away From Biotech Stocks

BioMarin Pharmaceutical Recent News

Short Sellers Still Attracted To Biotech Stocks

3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)

Surges In Biotech Short Interest (INCY, PCYC, REGN)

Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)

Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)

BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)

Biogen Idec, Pharmacyclics See Surges In Short Interest (BIIB, CELG, PCYC)

Gilead Sciences Leads In Rising Short Interest Among Biotechs

Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)

Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)

BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November

Dendreon, Pharmacyclics and Other Biotech Takeover Targets

Wells Fargo Resumes Coverage On BioMarin With $23-$28 Valuation Range